HBI Spotlight

 

Statutory insurers protect their hospitals, private pay markets look bleak

The post-COVID-19 financial outlook for private hospitals in Western Europe is becoming clearer. Those in statutory insurance-funded markets are likely to be protected by the public payor while private insurers look unlikely to shoulder the burden. And reimbursement for any COVID-19 care will barely make up the difference. 

UAE mass tests while private hospital revenues drop 50%

The UAE's decision to mass-test its population for COVID-19 and develop responses at the federal rather than emirate-level look to be paying dividends, notwithstanding its very young population. But how far is the private sector involved in the response, both in the UAE and neighbouring Saudi Arabia? HBI talks to local hospital, lab and advisory sources. 

Booking data shows outpatient has all but stopped

Patient footfall for outpatient care across the world has all but stopped. Exclusive data from DocPlanner shows which specialities have seen the biggest drop in appointments booked and where telemedicine is really picking up some of the slack. We assess this against outpatient volumes in Singapore during SARS to see when it might pick up.

COVID-19: Lockdowns and travel restrictions hit emerging market hospitals

Nationwide lockdowns and travel restrictions are hitting private hospital chains in India, Turkey and Southeast Asia, where the biggest groups garner 10-15% of revenues from international patients. HBI talks to an India-based source to find out more and looks at how operators are faring.

Labs stand to lose at least third of routine testing volumes

Labs across Europe are set to lose at best a third and at worst all of their routine testing volumes as healthcare systems narrow their focus on coronavirus and patients stay away. The picture is even bleaker for imaging groups.

Surgeries cancelled as for-profits drafted into coronavirus fight

Public elective surgeries are being cancelled across Europe, replaced in part by additional for-profit outsourcing, and governments are buying private hospital capacity for an expected flood of COVID-19 cases. In some countries, the stop on electives is across both public and private sectors. HBI investigates.

COVID-19: Care sector confronts crisis, hospitals hit hard

In the second of our two-part deep dive into how COVID-19 is hitting healthcare markets across EMEA, we ask how hospitals are coping with spiralling staff sickness and a flood of patients, and whether the care and dialysis sectors can stay afloat given the risk the virus poses to their most vulnerable patients.

COVID-19: Threats and opportunities

Covid-19 is going to have a huge impact on for-profit healthcare services. In the first of a two-part report, we look at what that will be at a sector and country level. Digital health looks like being a winner, Ping An claims online consultations are up tenfold, with the spectre of a crash in elective procedures hanging over for-profit hospitals and specialist outpatient chains. We also look at the likely impact on M&A.  The second part of this report, focussing on the care sector, will be published next week.

NMC shares suspended after CEO fired

Trading in the shares of scandal-hit NMC Health, the UAE’s largest for-profit healthcare provider, has been suspended. The move follows hot on the heels of the removal of the CEO, and the discovery of unauthorised off-balance sheet financing.

Find Us